In addition, the detection rate of DCIS, both among BRCA1/2 mutation carriers and non-carriers, is highly dependent on the surveillance offered, i.e., mammography, breast ultrasound, MRI and preventive mastectomy [34]. Here, BRCA1 is linked to ductal breast carcinoma in situ.